Voyager Therapeutics
Charlotte Chung has had an extensive career in neuroscience research, working in various roles ranging from Research Assistant to Director of Research. With a PhD in Neuroscience, Charlotte (Hiu-Yan) has contributed significantly to projects involving Parkinson's disease immunotherapy and the study of alpha synuclein aggregates in relation to Parkinson's disease. Their expertise also includes proteomic analysis and optimizing experimental strategies for research projects. Throughout their career, Charlotte has shown dedication and innovation in advancing the field of neuroscience.
Voyager Therapeutics
1 followers
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.